LEAF-4L7520
/ Strasbourg Europe Cancer Institute, Leaf 4 Life, University Hospitals of Strasbourg
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 04, 2020
LEAF-4L6715: A Study of Trans Crocetin in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Disease (LEAF-4L7520/4L6715)
(clinicaltrials.gov)
- P1/2; N=180; Recruiting; Sponsor: Institut de Cancerologie Strasbourg Europe; Trial primary completion date: Jul 2020 ➔ Dec 2020
Clinical • Trial primary completion date • Acute Respiratory Distress Syndrome • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
May 07, 2020
LEAF-4L6715: A Study of Trans Crocetin in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Disease (LEAF-4L7520/4L6715)
(clinicaltrials.gov)
- P1/2; N=180; Recruiting; Sponsor: Institut de Cancerologie Strasbourg Europe
Clinical • New P1/2 trial
1 to 2
Of
2
Go to page
1